Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tangning Tongluo Capsule placebo-controlled trial in newly diagnosed type 2 diabetes
ChiCTR1800014939Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Guizhou Medical University
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Tangning Tongluo Capsule in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Affiliated Hospital of Guizhou Medical University. Primary endpoint: Change in HbA1c from baseline to week 24. Started Jul 2017; status: recruiting.
02
Drugs
Tangning Tongluo Capsule
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR1800014939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014939.